Published October 2019 | Version v1
Journal article

METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy

  • 1. The Second Affiliated Hospital of Nanchang University, Department of General Surgery (China)

Description

Background

Autophagy plays an important role in regulating cisplatin (CDDP) resistance in gastric cancer cells. However, the underlying mechanism of methioninase (METase) in the regulation of autophagy and CDDP resistance of gastric cancer cells is still not clear.

Materials and methods

Western blot was used to detect the levels of autophagy-related proteins, multidrug-resistant 1 (MDR-1), and FoxM1 protein. LncRNA HULC was detected by qRT-PCR. Cell viability was detected using CCK-8 assay. The interaction between lncRNA HULC and FoxM1 was confirmed by RNA pull-down and RIP assay.

Results

Lentiviral vector carrying METase (LV-METase) suppressed autophagy and CDDP resistance of drug-resistant gastric cancer cells. LncRNA HULC was significantly downregulated in drug-resistant gastric cancer cells transfected with LV-METase. Besides, we found that lncRNA HULC interacted with FoxM1. In addition, METase suppressed autophagy to reduce CDDP resistance of drug-resistant gastric cancer cells through regulating HULC/FoxM1, and interfering HULC suppressed autophagy to reduce CDDP resistance of drug-resistant gastric cancer cells through regulating FoxM1. Finally, interfering HULC inhibited tumor growth in vivo.

Conclusion

METase suppressed autophagy to reduce CDDP resistance of drug-resistant gastric cancer cells through regulating HULC/FoxM1 pathway.

Additional details

Identifiers

Publishing Information

Journal Title
Journal of Cancer Research and Clinical Oncology
Journal Volume
145
Journal Issue
10
Journal Page Range
p. 2507-2517
ISSN
0171-5216
CODEN
JCROD7

INIS

Country of Publication
Germany
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54092116
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
DRUGS; IN VIVO; NEOPLASMS; POLYMERASE CHAIN REACTION; PROTEINS; RNA
Descriptors DEC
DISEASES; GENE AMPLIFICATION; NUCLEIC ACIDS; ORGANIC COMPOUNDS

Optional Information

Copyright
Copyright (c) 2019 Springer-Verlag GmbH Germany, part of Springer Nature